Novartis

ORG Health Care / Pharmaceuticals Momentum 11.2 NORMAL Primary: Spectral Shift

$62B revenue (2025), Basel-based Novartis operates across oncology, cardiology, and gene therapy. CEO Vas Narasimhan joined Anthropic's board as pharma deepens AI ties for drug discovery and development acceleration.

CEO Vas Narasimhan joined Anthropic's board of directors; expanding AI partnerships across Big Pharma sector
-0.40
PSI Score
11.2
Momentum
1%
Confidence
5
Connections
Connected Entities
Merck Pfizer Anthropic China DOD CEO AstraZeneca Ohio Houston Massachusetts
Watch This Entity
PSI Intelligence
30-Day Trend
2026-03-19 2026-04-18 14 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.136
Narrative Drift
0.000
Spectral Shift
831.349
Sentiment-Momentum Divergence
0.000
Source Concentration
0.905
Peer Comparison
N/A
Sector Rank
+0.00
Peer Z-Score
0%
Sector Percentile
Network Analysis
5 Degree Centrality
Centrality History
2026-03-19 2026-04-18 14 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 31 STRENGTHENED
Pfizer 31 STRENGTHENED
Anthropic 4 STABLE
China 3 STABLE
DOD 2 NEW
CEO 2 STABLE
AstraZeneca 2 NEW
Ohio 1 NEW
Houston 1 NEW
Massachusetts 1 NEW
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-04-18 ← Intelligence Network